Evaluation of clinical outcomes in patients with dry eye disease using lubricant eye drops containing polyethylene glycol or carboxymethylcellulose
- PMID: 24403819
- PMCID: PMC3883617
- DOI: 10.2147/OPTH.S53822
Evaluation of clinical outcomes in patients with dry eye disease using lubricant eye drops containing polyethylene glycol or carboxymethylcellulose
Abstract
Background: The purpose of this study was to compare changes in corneal staining in patients with dry eye after 6 weeks of treatment with Systane® Gel Drops or Refresh Liquigel® lubricant eye drops.
Methods: Patients aged ≥18 years with a sodium fluorescein corneal staining sum score of ≥3 in either eye and best-corrected visual acuity of 0.6 logarithm of the minimum angle of resolution or better in each eye who were using a lubricant eye gel or ointment for dry eye were included in this randomized, parallel-group, multicenter, double-blind trial. Patients were randomized to four times daily Systane® Gel Drops (polyethylene glycol 400 0.4% and propylene glycol 0.3%) or Refresh LiquiGel® Drops (carboxymethylcellulose sodium 1%) for 6 weeks. The primary efficacy outcome was mean change from baseline to week 6 in sodium fluorescein corneal staining. Supportive efficacy outcomes included conjunctival staining, tear film break-up time, Patient Global Assessment of Improvement, Impact of Dry Eye on Everyday Life (IDEEL) Treatment Satisfaction/Treatment Bother Questionnaire, Single Symptom Comfort Scale, and Ocular Symptoms Questionnaire. The safety analysis comprised recording of adverse events.
Results: In total, 147 patients (Systane group, n=73; Refresh group, n=74; mean ± standard deviation age, 57±16 years) were enrolled and included in the safety and efficacy analyses. Corneal staining was significantly reduced from baseline to week 6 for Systane and Refresh (-3.4±2.5 and -2.5±2.6 units, respectively; P<0.0001, t-test), with a significantly greater improvement with Systane versus Refresh (P=0.0294). Results for conjunctival staining, tear film break-up time, and patient-reported outcome questionnaires were not statistically different between groups. No safety issues were identified; adverse events were reported by 19% of patients with Systane and 30% of patients with Refresh eye drops.
Conclusion: Systane Gel Drops were associated with significantly better corneal staining scores versus Refresh Liquigel eye drops in patients with dry eye. Supportive efficacy outcomes were not significantly different between groups. Both treatments were well tolerated.
Keywords: Refresh Liquigel; Systane Gel Drops; artificial tears; corneal staining; patient-reported outcomes.
Figures




Similar articles
-
An evaluation of tear film breakup time extension and ocular protection index scores among three marketed lubricant eye drops.Cornea. 2007 Sep;26(8):949-52. doi: 10.1097/ICO.0b013e3180de1c38. Cornea. 2007. PMID: 17721294 Clinical Trial.
-
Corneal staining reductions observed after treatment with Systane Lubricant Eye Drops.Adv Ther. 2008 Nov;25(11):1191-9. doi: 10.1007/s12325-008-0112-0. Adv Ther. 2008. PMID: 18972076
-
A randomized clinical evaluation of the safety of Systane Lubricant Eye Drops for the relief of dry eye symptoms following LASIK refractive surgery.Clin Ophthalmol. 2008 Dec;2(4):973-9. doi: 10.2147/opth.s4475. Clin Ophthalmol. 2008. PMID: 19668456 Free PMC article.
-
Novel hydroxypropyl-guar gellable lubricant eye drops for treatment of dry eye.Adv Ther. 2010 Oct;27(10):681-90. doi: 10.1007/s12325-010-0052-3. Epub 2010 Aug 26. Adv Ther. 2010. PMID: 20803266 Review.
-
Propylene Glycol and Hydroxypropyl Guar Nanoemulsion - Safe and Effective Lubricant Eye Drops in the Management of Dry Eye Disease.Clin Ophthalmol. 2022 Oct 10;16:3311-3326. doi: 10.2147/OPTH.S377960. eCollection 2022. Clin Ophthalmol. 2022. PMID: 36237486 Free PMC article. Review.
Cited by
-
The pathophysiology, diagnosis, and treatment of dry eye disease.Dtsch Arztebl Int. 2015 Jan 30;112(5):71-81; quiz 82. doi: 10.3238/arztebl.2015.0071. Dtsch Arztebl Int. 2015. PMID: 25686388 Free PMC article. Review.
-
An evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye.Clin Ophthalmol. 2015 Feb 5;9:235-43. doi: 10.2147/OPTH.S75297. eCollection 2015. Clin Ophthalmol. 2015. PMID: 25709384 Free PMC article.
-
Real-life results of switching from preserved to preservative-free artificial tears containing hyaluronate in patients with dry eye disease.Clin Ophthalmol. 2018 Aug 23;12:1519-1525. doi: 10.2147/OPTH.S160053. eCollection 2018. Clin Ophthalmol. 2018. PMID: 30197497 Free PMC article.
-
Over the counter (OTC) artificial tear drops for dry eye syndrome.Cochrane Database Syst Rev. 2016 Feb 23;2(2):CD009729. doi: 10.1002/14651858.CD009729.pub2. Cochrane Database Syst Rev. 2016. PMID: 26905373 Free PMC article.
-
Formulation Considerations for the Management of Dry Eye Disease.Pharmaceutics. 2021 Feb 3;13(2):207. doi: 10.3390/pharmaceutics13020207. Pharmaceutics. 2021. PMID: 33546193 Free PMC article. Review.
References
-
- Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BD. Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea. 2012;31(5):472–478. - PubMed
-
- International Dry Eye Workshop The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Workshop. Ocul Surf. 2007;5(2):75–92. - PubMed
-
- McGinnigle S, Naroo SA, Eperjesi F. Evaluation of dry eye. Surv Ophthalmol. 2012;57(4):293–316. - PubMed
-
- Jacobi C, Kruse FE, Cursiefen C. Prospective, randomized, controlled comparison of Systane UD eye drops versus Visine Intensiv 1% EDO eye drops for the treatment of moderate dry eye. J Ocul Pharmacol Ther. 2012;28(6):598–603. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical